| Stage C | 18 (30%) | 6 (33.3%) | 12 (66.7%) |
| 6 (33.3%) | 12 (66.7%) |
| 10 (55.6%) | 8 (44.4%) |
|
| Stage D | 17 (28.3%) | 2 (11.8%) | 15 (88.2%) | 5 (29.4%) | 12 (70.6%) | 14 (82.4%) | 3 (17.6%) | |||
| AJCC stage |
|
|
|
|
|
|
|
|
|
|
| Stage I | 14 (23.3%) | 14 (100%) | 0 (0%) | <0.001§ | 14 (100%) | 0 (0%) | <0.001§ | 2 (14.3%) | 12 (85.7%) | <0.001§ |
| Stage II | 12 (20%) | 8 (66.7%) | 4 (33.3%) | 7 (58.3%) | 5 (41.7%) | 3 (25%) | 9 (75%) | |||
| Stage III | 17 (28.3%) | 5 (29.4%) | 12 (70.6%) | 5 (29.4%) | 12 (70.6%) | 10 (58.8%) | 7 (41.2%) | |||
| Stage IV | 17 (28.3%) | 2 (11.8%) | 15 (88.2%) | 5 (29.4%) | 12 (70.6%) | 14 (82.4%) | 3 (17.6%) | |||
| COX2 |
|
|
|
|
|
|
|
|
|
|
| Low | 29 (48.3%) |
|
|
| 22 (75.9%) | 7 (24.1%) | <0.001‡ | 8 (27.6%) | 21 (72.4%) | 0.002‡ |
| High | 31 (51.7%) |
|
| 9 (29%) | 22 (71%) | 21 (67.7%) | 10 (32.3%) | |||
| Cyclin D1 |
|
|
|
|
|
|
|
|
|
|
| Low | 31 (51.7%) | 22 (71%) | 9 (29%) | <0.001‡ |
|
|
| 9 (29%) | 22 (71%) | 0.002‡ |
| High | 29 (48.3%) | 7 (24.1%) | 22 (75.9%) |
|
| 20 (69%) | 9 (31%) | |||
| P21 |
|
|
|
|
|
|
|
|
|
|
| Low | 29 (48.3%) | 8 (27.6%) | 21 (72.4%) | 0.002‡ | 9 (31%) | 20 (69%) | 0.002‡ |
|
|
|
| High | 31 (51.7%) | 21 (67.7%) | 10 (32.3%) | 22 (71%) | 9 (29%) |
|
|